MedTrace Logo

Quadruple and Phytomedicine-based Therapies in H. Pylori Infection

NCT02004197 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 176

Last updated 2013-12-09

No results posted yet for this study

Summary

Helicobacter pylori is strongly associated to the development of gastrointestinal disorders. Emerging antibiotic resistance and poor patient compliance of modern therapies has resulted in significant eradication failure. Clinical trial was conducted to see the efficacy of current quadruple and phytomedicine-based therapies for the eradication of H. pylori infection and relief in its associated symptoms in Pakistan.

Conditions

  • Helicobacter Pylori [H. Pylori] as the Cause of Diseases

Interventions

DRUG

Quadruple Allopathic therapy

DRUG

Pylorex plus

Sponsors & Collaborators

  • Hafiz Muhammad Asif

    lead OTHER

Principal Investigators

  • Khan Usman Ghani, Ph. D · Hamdard University Karachi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2012-09-30
Completion
2013-01-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02004197 on ClinicalTrials.gov